Detalles de la búsqueda
1.
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study.
Ann Oncol
; 26(11): 2311-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26362568
2.
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.
Ann Oncol
; 24(2): 441-448, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23041589
3.
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.
J Clin Oncol
; 41(2): 154-162, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603541
4.
Isolated unilateral facial nerve palsy: an unusual manifestation of recurrent diffuse large B-cell lymphoma.
J Eur Acad Dermatol Venereol
; 30(6): 1033-5, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25753517
5.
Imaging guiding therapy development in lymphoma.
Clin Pharmacol Ther
; 84(4): 443-5, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18802425
6.
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.
Blood Cancer J
; 7(8): e595, 2017 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841207
7.
Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity.
Leukemia
; 19(5): 759-66, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15759034
8.
Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancer.
J Clin Oncol
; 19(4): 954-9, 2001 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11181657
9.
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
J Clin Oncol
; 19(2): 389-97, 2001 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11208830
10.
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
J Clin Oncol
; 18(17): 3135-43, 2000 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10963642
11.
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
J Clin Oncol
; 16(8): 2825-33, 1998 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9704735
12.
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Leuk Lymphoma
; 46(11): 1569-73, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16236611
13.
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens.
J Leukoc Biol
; 69(1): 81-8, 2001 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11200072
14.
Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma.
Blood Cancer J
; 5: e346, 2015 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314988
15.
Monoclonal antibodies in the treatment of human B-cell malignancies.
Leuk Lymphoma
; 31(3-4): 237-49, 1998 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-9869188
16.
Follicular lymphoma following liver transplantation: report of a unique case with review of the literature.
Transplant Proc
; 36(9): 2782-6, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15621149
17.
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
Nat Commun
; 5: 3856, 2014 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24920014
18.
Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.
Leukemia
; 32(2): 565-569, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29026208
19.
Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.
Blood Cancer J
; 7(2): e526, 2017 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28157213
20.
Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.
Leukemia
; 31(4): 988-991, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28035137